Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue

[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease

(2015) Ryuichi Harada et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Tau imaging: early progress and future directions

(2015) Victor L Villemagne et al.   LANCET NEUROLOGY

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease

(2014) Mitsuru Shinohara et al.   BRAIN

Tau PET Imaging in Alzheimer’s Disease

(2014) Nobuyuki Okamura et al.   Current Neurology and Neuroscience Reports

Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease

(2013) N. Okamura et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

(2013) Masahiro Maruyama et al.   NEURON

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology

(2012) Ryuichi Harada et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

Amyloid Imaging in Early Detection of Alzheimer’s Disease

(2010) Agneta Nordberg   Neurodegenerative Diseases

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies

(2009) Paul W. Thompson et al.   JOURNAL OF NEUROCHEMISTRY

Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment

(2009) N. Tolboom et al.   NEUROLOGY

Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment

(2008) J. R. Barrio et al.   Journal of Nutrition Health & Aging